The role of dietary phytochemicals in the carcinogenesis via the modulation of miRNA expression

[1]  T. Kwon,et al.  Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine , 2020, EPMA Journal.

[2]  M. Adamkov,et al.  Chemopreventive and Therapeutic Efficacy of Cinnamomum zeylanicum L. Bark in Experimental Breast Carcinoma: Mechanistic In Vivo and In Vitro Analyses , 2020, Molecules.

[3]  T. Kwon,et al.  Dietary phytochemicals as the potential protectors against carcinogenesis and their role in cancer chemoprevention , 2020, Clinical and Experimental Medicine.

[4]  P. Kubatka,et al.  Therapeutic Potential of Plant Phenolic Acids in the Treatment of Cancer , 2020, Biomolecules.

[5]  S. Samuel,et al.  Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression , 2020, Biomolecules.

[6]  S. Samuel,et al.  Flavonoids in Cancer and Apoptosis , 2018, Cancers.

[7]  D. Baranenko,et al.  The inhibitory effect of Filipendula ulmaria (L.) Maxim. on colorectal carcinogenesis induced in rats by methylnitrosourea. , 2018, Journal of ethnopharmacology.

[8]  See-Hyoung Park,et al.  Indole-3-Carbinol Induces Apoptosis in Human Osteosarcoma MG-63 and U2OS Cells , 2018, BioMed research international.

[9]  E. Arısan,et al.  Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-κB activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells , 2018, Molecular Biology Reports.

[10]  T. Kwon,et al.  Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach , 2018, EPMA Journal.

[11]  Qiong Lu,et al.  Curcumin Suppresses microRNA-7641-Mediated Regulation of p16 Expression in Bladder Cancer. , 2018, The American journal of Chinese medicine.

[12]  Y. Ba,et al.  Exosome-Derived miR-130a Activates Angiogenesis in Gastric Cancer by Targeting C-MYB in Vascular Endothelial Cells. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  A. Sahebkar,et al.  The molecular mechanisms of curcumin’s inhibitory effects on cancer stem cells , 2018, Journal of cellular biochemistry.

[14]  S. Samuel,et al.  The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers , 2018, Cancers.

[15]  G. Meister,et al.  Regulation of microRNA biogenesis and its crosstalk with other cellular pathways , 2018, Nature Reviews Molecular Cell Biology.

[16]  Chi-Tang Ho,et al.  Prevention of Breast Cancer by Natural Phytochemicals: Focusing on Molecular Targets and Combinational Strategy , 2018, Molecular nutrition & food research.

[17]  J. Iqbal,et al.  Role of dietary phytochemicals in modulation of miRNA expression: Natural swords combating breast cancer , 2018 .

[18]  Tao Zhang,et al.  Evaluation of curcumin, a natural product in turmeric, on Burkitt lymphoma and acute myeloid leukemia cancer stem cell markers. , 2018, Future oncology.

[19]  Jun Ho Kim,et al.  Cruciferous vegetables and colorectal cancer prevention through microRNA regulation: A review , 2018, Critical reviews in food science and nutrition.

[20]  P. Kubatka,et al.  Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention , 2018, Environmental Health and Preventive Medicine.

[21]  C. Peng,et al.  Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation , 2018, Front. Endocrinol..

[22]  Barbara Pasculli,et al.  Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine. , 2018, Seminars in cancer biology.

[23]  V. Holubekova,et al.  miRNA in a multiomic context for diagnosis, treatment monitoring and personalized management of metastatic breast cancer. , 2018, Future oncology.

[24]  Yuwei Zhang,et al.  Sulforaphane promotes apoptosis, and inhibits proliferation and self-renewal of nasopharyngeal cancer cells by targeting STAT signal through miRNA-124-3p. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  Sebastien M. Weyn-Vanhentenryck,et al.  LIN28 Selectively Modulates a Subclass of Let-7 MicroRNAs. , 2018, Molecular cell.

[26]  T. Ochiya,et al.  Regulatory role of resveratrol, a microRNA-controlling compound, in HNRNPA1 expression, which is associated with poor prognosis in breast cancer , 2018, Oncotarget.

[27]  Liang Tang,et al.  MiR‐127‐3p inhibits cell growth and invasiveness by targeting ITGA6 in human osteosarcoma , 2018, IUBMB life.

[28]  Xuerui Yang,et al.  The number of titrated microRNA species dictates ceRNA regulation , 2018, Nucleic acids research.

[29]  Gary Wilk,et al.  regQTLs: Single nucleotide polymorphisms that modulate microRNA regulation of gene expression in tumors , 2018, PLoS genetics.

[30]  F. Gao,et al.  MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4 , 2018, Cancer biology & therapy.

[31]  Li Ma,et al.  MicroRNAs and metastasis: small RNAs play big roles , 2017, Cancer and Metastasis Reviews.

[32]  S. Song,et al.  miR-218 and miR-129 regulate breast cancer progression by targeting Lamins. , 2018, Biochemical and biophysical research communications.

[33]  Cheng Chen,et al.  New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications , 2018, Molecular Cancer.

[34]  Hong-zhao Li,et al.  miR‐122 promotes metastasis of clear‐cell renal cell carcinoma by downregulating Dicer , 2018, International journal of cancer.

[35]  H. Kwon,et al.  MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3 , 2018, Cell Death & Disease.

[36]  Shiang-Fu Huang,et al.  Differential microRNA expression in breast cancer with different onset age , 2018, PloS one.

[37]  Amir Mehrgou,et al.  Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease , 2017, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[38]  A. Navarro,et al.  Epigenetic regulation mechanisms of microRNA expression , 2017, Biomolecular concepts.

[39]  C. Gong,et al.  MicroRNAs and cancer: Key paradigms in molecular therapy. , 2017, Oncology letters.

[40]  Shaoying Lu,et al.  MicroRNA-93 promotes proliferation and metastasis of gastric cancer via targeting TIMP2 , 2017, PloS one.

[41]  Longchang Huang,et al.  Curcumin Suppresses the Colon Cancer Proliferation by Inhibiting Wnt/β-Catenin Pathways via miR-130a , 2017, Front. Pharmacol..

[42]  B. Han,et al.  MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer , 2017, Cellular Physiology and Biochemistry.

[43]  G. Yao,et al.  MicroRNA-320 inhibits cell proliferation and invasion in breast cancer cells by targeting SOX4 , 2017, Oncology letters.

[44]  Yihao Wang,et al.  Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma , 2017, Medicine.

[45]  Jian-fei Song,et al.  Silencing DNA methyltransferase 1 leads to the activation of the esophageal suppressor gene p16 in vitro and in vivo. , 2017, Oncology letters.

[46]  M. Wnuk,et al.  Sulforaphane-Induced Cell Cycle Arrest and Senescence are accompanied by DNA Hypomethylation and Changes in microRNA Profile in Breast Cancer Cells , 2017, Theranostics.

[47]  Y. Bao,et al.  The Role of MicroRNAs in the Chemopreventive Activity of Sulforaphane from Cruciferous Vegetables , 2017, Nutrients.

[48]  Liangchen Niu,et al.  miR-138 inhibits gastric cancer growth by suppressing SOX4. , 2017, Oncology reports.

[49]  M. Michael,et al.  MicroRNA Biogenesis in Hypoxia. , 2017, MicroRNA.

[50]  L. Wang,et al.  MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer , 2017, Cancer Gene Therapy.

[51]  Li-Jun Chen,et al.  Genistein suppresses retinoblastoma cell viability and growth and induces apoptosis by upregulating miR-145 and inhibiting its target ABCE1 , 2017, Molecular vision.

[52]  Liyan Bi,et al.  miR-182-5p improves the viability, mitosis, migration, and invasion ability of human gastric cancer cells by down-regulating RAB27A , 2017, Bioscience reports.

[53]  M. Adamkov,et al.  Antineoplastic effects of clove buds (Syzygium aromaticum L.) in the model of breast carcinoma , 2017, Journal of cellular and molecular medicine.

[54]  Wende Li,et al.  MicroRNA-378 enhances inhibitory effect of curcumin on glioblastoma , 2017, Oncotarget.

[55]  Wende Li,et al.  MicroRNA-378 enhances inhibitory effect of curcumin on glioblastoma , 2017, Oncotarget.

[56]  X. Bao,et al.  Effects of miR-21 on proliferation and apoptosis in human gastric adenocarcinoma cells , 2017, Oncology letters.

[57]  Chien-Feng Li,et al.  Hypoxia-regulated MicroRNA-210 Overexpression is Associated with Tumor Development and Progression in Upper Tract Urothelial Carcinoma , 2017, International journal of medical sciences.

[58]  J. K. Kim,et al.  Recent studies on resveratrol and its biological and pharmacological activity , 2017, EXCLI journal.

[59]  H. Guan,et al.  miR-365 induces hepatocellular carcinoma cell apoptosis through targeting Bcl-2 , 2017, Experimental and therapeutic medicine.

[60]  Yanxia Hu,et al.  Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[61]  Jacek Niklinski,et al.  MicroRNAs as novel targets and tools in cancer therapy. , 2017, Cancer letters.

[62]  S. Biffo,et al.  Role of microRNAs in translation regulation and cancer , 2017, World journal of biological chemistry.

[63]  F. Slack,et al.  MicroRNA therapeutics: towards a new era for the management of cancer and other diseases , 2017, Nature Reviews Drug Discovery.

[64]  D. Baranenko,et al.  The inhibiting activity of meadowsweet extract on neurocarcinogenesis induced transplacentally in rats by ethylnitrosourea , 2017, Journal of Neuro-Oncology.

[65]  M. Todaro,et al.  MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer , 2017, Oncotarget.

[66]  Jingwen Liu,et al.  MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell , 2016, International journal of nanomedicine.

[67]  Y. Lin,et al.  Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways , 2016, Acta Pharmacologica Sinica.

[68]  L. Pan,et al.  MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN , 2016, Oncotarget.

[69]  Yuan Yang,et al.  MicroRNA-210 promotes cancer angiogenesis by targeting fibroblast growth factor receptor-like 1 in hepatocellular carcinoma. , 2016, Oncology reports.

[70]  C. Cogoni,et al.  MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions , 2016, International journal of molecular sciences.

[71]  C. Tsao,et al.  Emerging role of microRNA-21 in cancer (Review) , 2016 .

[72]  George A. Calin,et al.  microRNA Therapeutics in Cancer — An Emerging Concept , 2016, EBioMedicine.

[73]  Ying Wang,et al.  MicroRNA-200c is involved in proliferation of gastric cancer by directly repressing p27Kip1 , 2016, Biochemistry and biophysics reports.

[74]  X. Shu,et al.  Long‐term soy consumption and tumor tissue MicroRNA and gene expression in triple‐negative breast cancer , 2016, Cancer.

[75]  W. Moon,et al.  Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A , 2016, BMC Cancer.

[76]  W. Kuhn,et al.  Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures , 2016, Tumor Biology.

[77]  Miki Ohira,et al.  Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes , 2016, Journal of Human Genetics.

[78]  Kang Zhang,et al.  MicroRNA Expression Profile on Solid Subtype of Invasive Lung Adenocarcinoma Reveals a Panel of Four miRNAs to Be Associated with Poor Prognosis in Chinese Patients , 2016, Journal of Cancer.

[79]  J. P. Rigalli,et al.  The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters. , 2016, Cancer letters.

[80]  Ting Deng,et al.  Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer , 2016, Oncotarget.

[81]  H. Salehiniya,et al.  Incidence and Mortality and Epidemiology of Breast Cancer in the World. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[82]  Zhihua Liu,et al.  MicroRNA‐548j functions as a metastasis promoter in human breast cancer by targeting Tensin1 , 2016, Molecular oncology.

[83]  L. Gulyaeva,et al.  Regulatory mechanisms of microRNA expression , 2016, Journal of Translational Medicine.

[84]  K. Nakanishi.  Anatomy of RISC: how do small RNAs and chaperones activate Argonaute proteins? , 2016, Wiley interdisciplinary reviews. RNA.

[85]  Moustapha Kassem,et al.  microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection , 2016, Scientific Reports.

[86]  Junbo Dong,et al.  miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma , 2016, Journal of bone oncology.

[87]  Lin He,et al.  Phytochemical regulation of the tumor suppressive microRNA, miR‐34a, by p53‐dependent and independent responses in human breast cancer cells , 2016, Molecular carcinogenesis.

[88]  J. Meléndez-Zajgla,et al.  miR‐10b expression in breast cancer stem cells supports self‐renewal through negative PTEN regulation and sustained AKT activation , 2016, EMBO reports.

[89]  J. Biagi,et al.  Research output and the public health burden of cancer: is there any relationship? , 2016, Current oncology.

[90]  M. Garcia-Conesa,et al.  Comprehensive characterization of the effects of ellagic acid and urolithins on colorectal cancer and key-associated molecular hallmarks: MicroRNA cell specific induction of CDKN1A (p21) as a common mechanism involved. , 2016, Molecular nutrition & food research.

[91]  J. Reményi,et al.  The loop structure and the RNA helicase p72/DDX17 influence the processing efficiency of the mice miR-132 , 2016, Scientific Reports.

[92]  T. Ma,et al.  Hydroxymethylation of microRNA-365-3p Regulates Nociceptive Behaviors via Kcnh2 , 2016, The Journal of Neuroscience.

[93]  Wei Shi,et al.  MiR-449a promotes breast cancer progression by targeting CRIP2 , 2016, Oncotarget.

[94]  U. Das,et al.  Beneficial action of resveratrol: How and why? , 2016, Nutrition.

[95]  B. S. Sørensen,et al.  Hypoxia-regulated MicroRNAs in Gastroesophageal Cancer. , 2016, Anticancer research.

[96]  J. Yakisich,et al.  Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death , 2016, Cell Death & Disease.

[97]  J. Steitz,et al.  A heterotrimer model of the complete Microprocessor complex revealed by single-molecule subunit counting , 2016, RNA.

[98]  H. Tachibana,et al.  Epigallocatechin-3-O-gallate up-regulates microRNA-let-7b expression by activating 67-kDa laminin receptor signaling in melanoma cells , 2016, Scientific Reports.

[99]  G. Calin,et al.  Soy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein , 2016, Nutrition and cancer.

[100]  Chengping Hu,et al.  MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/β-catenin/ZEB1 signaling. , 2015, International journal of oncology.

[101]  Mark A Feitelson,et al.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. , 2015, Seminars in cancer biology.

[102]  H. Lan,et al.  miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[103]  H. Ying,et al.  Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer , 2015, Scientific Reports.

[104]  Solomon Habtemariam,et al.  Genistein and cancer: current status, challenges, and future directions. , 2015, Advances in nutrition.

[105]  Lei Li,et al.  miR-139 and miR-200c regulate pancreatic cancer endothelial cell migration and angiogenesis. , 2015, Oncology reports.

[106]  Haiyang Xie,et al.  Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma , 2015, Journal of experimental & clinical cancer research : CR.

[107]  Jian Zhu,et al.  Upregulation of miR-195 enhances the radiosensitivity of breast cancer cells through the inhibition of BCL-2. , 2015, International journal of clinical and experimental medicine.

[108]  Yin Li,et al.  MiR-126 regulated breast cancer cell invasion by targeting ADAM9. , 2015, International journal of clinical and experimental pathology.

[109]  J. Zhao,et al.  Breast Cancer: Epidemiology and Etiology , 2015, Cell Biochemistry and Biophysics.

[110]  R. Gregory,et al.  MicroRNA biogenesis pathways in cancer , 2015, Nature Reviews Cancer.

[111]  Q. Ma,et al.  MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7 , 2015, Tumor Biology.

[112]  P. Gál,et al.  Soy and Breast Cancer: Focus on Angiogenesis , 2015, International journal of molecular sciences.

[113]  Dongguo Li,et al.  Identification of Novel Breast Cancer Subtype-Specific Biomarkers by Integrating Genomics Analysis of DNA Copy Number Aberrations and miRNA-mRNA Dual Expression Profiling , 2015, BioMed research international.

[114]  Takahiro Ochiya,et al.  The Roles of MicroRNAs in Breast Cancer , 2015, Cancers.

[115]  Kenneth P. Nephew,et al.  Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer , 2015, Oncotarget.

[116]  S. Arora,et al.  Modulation of MicroRNAs by Phytochemicals in Cancer: Underlying Mechanisms and Translational Significance , 2015, BioMed research international.

[117]  Kyvan Dang,et al.  The Role of Hypoxia-Induced miR-210 in Cancer Progression , 2015, International journal of molecular sciences.

[118]  M. Kerin,et al.  Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring , 2015, Cancer and Metastasis Reviews.

[119]  H. Wildiers,et al.  Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management , 2015, Breast Cancer Research.

[120]  C. Klinge.  miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets , 2015, Molecular and Cellular Endocrinology.

[121]  Lu‐Hai Wang,et al.  Regulation of cancer metastasis by microRNAs , 2015, Journal of Biomedical Science.

[122]  V. Karpa,et al.  MiR-21 Enhances Melanoma Invasiveness via Inhibition of Tissue Inhibitor of Metalloproteinases 3 Expression: In Vivo Effects of MiR-21 Inhibitor , 2015, PloS one.

[123]  Hong Wang,et al.  Gene regulation mediated by microRNAs in response to green tea polyphenol EGCG in mouse lung cancer , 2014, BMC Genomics.

[124]  R. Tekade,et al.  Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[125]  Huirong Shi,et al.  MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer. , 2014, Oncology reports.

[126]  P. Vineis,et al.  MicroRNA expression in relation to different dietary habits: a comparison in stool and plasma samples. , 2014, Mutagenesis.

[127]  Y. Dodurga,et al.  Genistein-induced mir-23b expression inhibits the growth of breast cancer cells , 2014, Contemporary oncology.

[128]  K. Tu,et al.  Effects of microRNA‐30a on migration, invasion and prognosis of hepatocellular carcinoma , 2014, FEBS letters.

[129]  L. Cobiac,et al.  Dietary Manipulation of Oncogenic MicroRNA Expression in Human Rectal Mucosa: A Randomized Trial , 2014, Cancer Prevention Research.

[130]  C. Davis,et al.  The emerging role of microRNAs and nutrition in modulating health and disease. , 2014, Annual review of nutrition.

[131]  H. Hermeking,et al.  The p53/miR-34 axis in development and disease. , 2014, Journal of molecular cell biology.

[132]  Ke Huang,et al.  Hypoxia-induced miR-210 in epithelial ovarian cancer enhances cancer cell viability via promoting proliferation and inhibiting apoptosis. , 2014, International journal of oncology.

[133]  Wei Zhang,et al.  miR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma , 2014, Oncology reports.

[134]  Wei Zhao,et al.  miR-222 regulates the cell biological behavior of oral squamous cell carcinoma by targeting PUMA. , 2014, Oncology reports.

[135]  Cecilia Williams,et al.  Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells , 2014, Journal of visualized experiments : JoVE.

[136]  E. Sauter,et al.  Methylation and miRNA Effects of Resveratrol on Mammary Tumors vs. Normal Tissue , 2014, Nutrition and cancer.

[137]  Subbaya Subramanian,et al.  Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation , 2014, Front. Genet..

[138]  C. Wahlestedt,et al.  Non-coding RNAs as direct and indirect modulators of epigenetic regulation , 2014, Epigenetics.

[139]  Qun Zhou,et al.  Characterization of a Stem-like Subpopulation in Basal-like Ductal Carcinoma in Situ (DCIS) Lesions* , 2013, The Journal of Biological Chemistry.

[140]  Jian-Min Yuan.  Cancer prevention by green tea: evidence from epidemiologic studies. , 2013, The American journal of clinical nutrition.

[141]  F. Aqil,et al.  MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention. , 2013, Cancer letters.

[142]  P. Sharp,et al.  The role of miRNAs in regulating gene expression networks. , 2013, Journal of molecular biology.

[143]  F. Wang,et al.  The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer , 2013, International journal of molecular sciences.

[144]  C. Kang,et al.  Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. , 2013, Oncology reports.

[145]  Yaguang Xi,et al.  Hypoxia-regulated microRNAs in human cancer , 2013, Acta Pharmacologica Sinica.

[146]  R. Vyzula,et al.  Identification of MicroRNAs Regulated by Isothiocyanates and Association of Polymorphisms Inside Their Target Sites with Risk of Sporadic Colorectal Cancer , 2013, Nutrition and cancer.

[147]  T. Sellers,et al.  Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer , 2013, Oncogene.

[148]  B. Liu,et al.  MicroRNA miR-491-5p Targeting both TP53 and Bcl-XL Induces Cell Apoptosis in SW1990 Pancreatic Cancer Cells through Mitochondria Mediated Pathway , 2012, Molecules.

[149]  Wei Duan,et al.  Apoptosis and microRNA aberrations in cancer , 2012, Clinical and experimental pharmacology & physiology.

[150]  A. Hata,et al.  Smad‐mediated regulation of microRNA biosynthesis , 2012, FEBS letters.

[151]  H. Allgayer,et al.  MicroRNA‐30a inhibits epithelial‐to‐mesenchymal transition by targeting Snai1 and is downregulated in non‐small cell lung cancer , 2012, International journal of cancer.

[152]  Chun-Wen Cheng,et al.  MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer , 2012, Breast Cancer Research and Treatment.

[153]  Feng Liu,et al.  Defective activities, but not secretions, resulting from gene point mutations of human mannan-binding lectin , 2012, Molecular medicine reports.

[154]  Justin L. Mott,et al.  miR‐25 targets TNF‐related apoptosis inducing ligand (TRAIL) death receptor‐4 and promotes apoptosis resistance in cholangiocarcinoma , 2012, Hepatology.

[155]  S. Rodriguez-Cuevas,et al.  MetastamiRs: Non-Coding MicroRNAs Driving Cancer Invasion and Metastasis , 2012, International journal of molecular sciences.

[156]  Min Su,et al.  miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2. , 2011, Molecular medicine reports.

[157]  M. Ladomery,et al.  MicroRNAs: their discovery, biogenesis, function and potential use as biomarkers in non-invasive prenatal diagnostics. , 2011, International journal of molecular epidemiology and genetics.

[158]  Leigh-Ann MacFarlane,et al.  MicroRNA: Biogenesis, Function and Role in Cancer , 2010, Current genomics.

[159]  E. Olson,et al.  Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. , 2010, Cancer cell.

[160]  Shuai Jiang,et al.  MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. , 2010, Cancer research.

[161]  John S Mattick,et al.  Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7* , 2009, Journal of Biological Chemistry.

[162]  Tian-Li Wang,et al.  MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer , 2008, PloS one.

[163]  M. Korpal,et al.  The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2* , 2008, Journal of Biological Chemistry.

[164]  Reuven Agami,et al.  Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation , 2007 .

[165]  Yuesheng Zhang,et al.  High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. , 2002, The Biochemical journal.

[166]  Yang Yang,et al.  MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1. , 2017, American journal of cancer research.

[167]  M. Amati,et al.  Use of potential dietary phytochemicals to target miRNA: Promising option for breast cancer prevention and treatment? , 2017 .

[168]  M. Qadir,et al.  miRNA: A Diagnostic and Therapeutic Tool for Pancreatic Cancer. , 2017, Critical reviews in eukaryotic gene expression.

[169]  Keisuke Ito,et al.  A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease. , 2017, International review of cell and molecular biology.

[170]  C. Tsao,et al.  Emerging role of microRNA-21 in cancer. , 2016, Biomedical reports.

[171]  G. Derosa,et al.  Ellagic Acid and Its Role in Chronic Diseases. , 2016, Advances in experimental medicine and biology.

[172]  Zhihua Liu,et al.  MicroRNA-548 j Functions as a Metastasis Promoter in Human Breast Cancer by Targeting Tensin 1 Running title : miR-548 j promotes breast cancer metastasis , 2016 .

[173]  Leaf Huang,et al.  In vivo delivery of miRNAs for cancer therapy: challenges and strategies. , 2015, Advanced drug delivery reviews.

[174]  L. J. Lee,et al.  Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog. , 2015, Biochimica et biophysica acta.

[175]  Shadan Ali,et al.  Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment. , 2012, American journal of translational research.

[176]  Jing Liu,et al.  MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN , 2012, Molecular and Cellular Biochemistry.

[177]  Dean A Fennell,et al.  MicroRNA regulation of core apoptosis pathways in cancer. , 2011, European journal of cancer.

[178]  Reuven Agami,et al.  Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. , 2007, The EMBO journal.